Raleigh--LipoScience.

PositionTriangle

RALEIGH--LipoScience revived plans to go public. The company, which sells a blood test that monitors risk for heart disease, wants to raise $86.25 million in its initial public offering. It abandoned plans to go public in 2002...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT